Chinese newco Brii launches with $260M

Arch Venture Partners and a syndicate of U.S. and Chinese investors launched Brii Biosciences (Shanghai, China) on Thursday with $260 million in committed capital and a series of high-profile partnerships

Read the full 304 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE